«Thus, it is clear that further studies must investigate an increasingly complex matrix of cell types and conditions to fully understand
the role of human genetic variation in disease.»
Not exact matches
Lead researcher Professor Vardhman Rakyan from QMUL said: «The fact that
genetic variation of ribosomal DNA seems to play such a major
role suggests that many
human genetics studies could be missing a key part
of the puzzle.
With the completion
of the first phase
of the
Human Genome Project in 2000, and the advent
of sequencing technologies that can detect gene
variations such as single nucleotide polymorphisms (SNPs), for the first time scientists have the tools in hand to find the key immune genes and
genetic networks that play
roles in vaccine response.
Through his
role in the UM Center for Genome Technology, part
of the Miller School
of Medicine, Dr. Hedges is actively involved in the incorporation
of novel genomic technologies into the process
of searching for the
genetic variation underlying
human disease risk.
This study
of human genetic variation and its relationship to health and disease involves a large number
of study participants and will capture not only common single nucleotide
variations but also rare copy number and structural variants that are increasingly thought to play an important
role in complex disease.
His research focuses on the use
of genomic approaches to uncover the functional impact
of human genetic variation, and especially its
role in causing severe Mendelian diseases.
His research focuses on understanding the
role of genetic variation in contributing to
human health and disease using mouse models
of human disease, and more recently exploiting technologies developed for biomedical research for application in the field
of genetic pest management.
His work focusses on the application
of contemporary genomic technologies to detect
genetic variation and evaluate its
role in
human disease.